Showing results (161-170 of 2,436) with videos related to

Sort By:
Pageof 244
European Journal of Human Genetics : EJHG|December 7, 2007
Polymorphisms in the cardiac sodium channel promoter displaying variant in vitro expression activityP Yang, T T Koopmann, A Pfeufer, et al.
Clinical Pharmacology and Therapeutics|November 21, 2013
Clinically actionable genotypes among 10,000 patients with preemptive pharmacogenomic testingS L Van Driest, Y Shi, E A Bowton, et al.
The Journal of Clinical Investigation|February 1, 1984
Encainide and its metabolites. Comparative effects in man on ventricular arrhythmia and electrocardiographic intervalsE L Carey, H J Duff, D M Roden, et al.
Clinical Pharmacology and Therapeutics|July 1, 1986
Encainide disposition in patients with renal failureR H Bergstrand, T Wang, D M Roden, et al.
Journal of Molecular and Cellular Cardiology|December 8, 2009
Selective gamma-ketoaldehyde scavengers protect Nav1.5 from oxidant-induced inactivationT Nakajima, S S Davies, E Matafonova, et al.
Clinical Pharmacology and Therapeutics|September 1, 1989
Recainam dose titration and pharmacokinetics in patients with resistant arrhythmiasR F Davies, M D Lineberry, C Funck-Brentano, et al.
The New England Journal of Medicine|June 21, 1990
The role of genetically determined polymorphic drug metabolism in the beta-blockade produced by propafenoneJ T Lee, H K Kroemer, D J Silberstein, et al.
Annals of Surgery|June 1, 1986
Indications for different modes of surgical therapy in medically refractory ventricular arrhythmiasJ W Hammon, D S Echt, W H Merrill, et al.
European Journal of Biochemistry|January 1, 1982
Tetramethyl-p-phenylenediamine oxidase of Pseudomonas aeruginosaT Yang
Pageof 244